50242-053Level 3
Rituxan (rituximab)
**Product type:** Human Prescription Drug
**Active ingredient:** RITUXIMAB
**Strength:** 10 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA103705)
**Pharmacologic class:** CD20-directed Antibody Interactions [MoA], CD20-directed Cytolytic Antibody [EPC]
GET
/api/v1/systems/ndc_fda/nodes/50242-053Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.